PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15103684

Environment-dependent down-modulation of CD45 cell surface expression on polymorphonuclear cells.

Ingrid Böhm
View original source ↗Export metadata ↓

Abstract

CD45, a transmembrane protein tyrosine phosphatase, regulates important cell functions. Its involvement in clearing tissues from dead or dying cells by polymorphonuclear cells (PMNs) is unclear. Therefore, in this study the influence of exogenous factors (e.g., temperature and phagocytosis) on the CD45 expression on PMNs (in patients with lupus erythematosus (LE) vs. controls) was analysed by flow cytometry. The data showed a significant down-regulation of CD45 at 4 degrees C in controls, but not on LE-PMNs. In the presence of targets, CD45 was significantly decreased (P<0.00002). Substrate-dependent down-regulation was greater in the presence of nuclei than in the presence of dead cells(68.98%+/-2.28% vs. 47.89%+/-2.75%; P<0.002), and on LE-PMNs than on control-PMNs (45.93%+/-4.92% vs. 53.65%+/-2.2%). Target pretreatment with anti-dsDNA antibody-containing serum resulted in a lower CD45 expression compared to treatment with normal serum. This effect was more pronounced on PMNs of LE patients than on those of controls. Phagocytosis was inversely correlated with CD45 expression (P<0.0007). These data suggest that phagocytic clearance of cellular debris by PMNs may modulate the function of the effector cells, and that anti-dsDNA antibodies apparently enhance the phagocytic clearance.

Explore related subjects

Antibodies, AntinuclearCell NucleusDNADown-RegulationFlow CytometryHumansLeukocyte Common AntigensLupus Erythematosus, SystemicNeutrophilsPhagocytesPhagocytosisTemperatureJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ingrid Böhm. 2004. Environment-dependent down-modulation of CD45 cell surface expression on polymorphonuclear cells.. https://doi.org/10.1002/jcla.20021

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

Structure of an anti-DNA fab complexed with a non-DNA ligand provides insights into cross-reactivity and molecular mimicry.

Antibodies that recognize DNA (anti-DNA) are part of the autoimmune response underlying systemic lupus erythematosus. To better understand molecular recognition by anti-DNA antibodies, crystallographic studies have been performed using an anti-ssDNA antigen-binding fragment (Fab) known as DNA-1. The previously determined structure of a DNA-1/dT5 complex revealed that thymine bases insert into a narrow groove, and that ligand recognition primarily involves the bases of DNA. We now report the 1.75-A resolution structure of DNA-1 complexed with the biological buffer HEPES (4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid). All three light chain complementarity-determining regions (CDRs) and HCDR3 contribute to binding. The HEPES sulfonate hydrogen bonds to His L91, Asn L50, and to the backbone of Tyr H100 and Tyr H100A. The Tyr side-chains of L32, L92, H100, and H100A form nonpolar contacts with the HEPES ethylene and piperazine groups. Comparison to the DNA-1/dT5 structure reveals that the dual recognition of dT5 and HEPES requires a 13-A movement of HCDR3. This dramatic structural change converts the combining site from a narrow groove, appropriate for the edge-on insertion of thymine bases, to one sufficiently wide to accommodate the HEPES sulfonate and piperazine. Isothermal titration calorimetry verified the association of HEPES with DNA-1 under conditions similar those used for crystallization (2 M ammonium sulfate). Interestingly, the presence of 2 M ammonium sulfate increases the affinities of DNA-1 for both HEPES and dT5, suggesting that non-polar Fab-ligand interactions are important for molecular recognition in highly ionic solvent conditions. The structural and thermodynamic data suggest a molecular mimicry mechanism based on structural plasticity and hydrophobic interactions.

Antibodies, Antinuclear↗
PubMed2004

Detection of anti-SSA antibodies by indirect immunofluorescence.

BACKGROUND: HEp-2 cells that overexpress the human 60-kDa SSA antigen have been used to improve sensitivity and specificity for the detection of anti-SSA antibodies by indirect immunofluorescence. We describe a survey on the detection of anti-SSA antibodies using a commercial substrate that overexpresses SSA. METHODS: The evaluation was done on 18 371 consecutive samples submitted to the laboratory for detection of anti-nuclear antibodies, from which 188 anti-SSA antibody-containing and clinically documented samples were obtained. The presence of anti-SSA antibodies produced a distinct bright speckled pattern with nucleolar staining in 10-20% of interphase cells. The identity of all anti-SSA antibodies was confirmed by dot-blot analysis. RESULTS: Samples containing anti-SSA antibodies were separated into three main groups: group I, distinctive SSA pattern and other nuclear staining (50%); group II, only the distinctive SSA pattern (29%); group III, nuclear staining but without the distinctive SSA pattern (21%). Anti-SSA antibodies with concurrent SSB antibodies were associated with group I, whereas anti-SSA antibodies with concurrent U(1)-RNP antibodies were associated with group III. Group I included mainly patients with Sjogren syndrome and systemic lupus erythematosus (SLE), whereas group III included patients with mixed connective tissue disease and SLE. Diseases not classically associated with the presence of anti-SSA antibodies were found in group II in >50% of the cases. CONCLUSIONS: SSA-positive individuals were identified in a population selected on the basis of HEp-2000 positivity. Our study highlights diseases associated with anti-SSA antibodies and associations between the presence of the distinctive SSA pattern on HEp-2000 and some clinical conditions.

Antibodies, Antinuclear↗